The Most Sold Supplement Worldwide Looks Less Glamorous Than You Think
Estimated reading time: 5 minutes
Key Takeaways
- The most sold supplement worldwide is multivitamins, a significant segment of the larger vitamins category.
- Market data indicates multivitamins generated $49.5 billion in 2025, reflecting strong global demand.
- Usage data shows multivitamins as the most commonly consumed supplements in the U.S., mirroring global trends.
- Despite their popularity, studies show no clear health benefits for healthy adults from daily multivitamin use.
- Multivitamins succeed due to consumer demand for convenience, reassurance, and protection against nutritional gaps, not necessarily proven health benefits.
If you ask what the most sold supplement worldwide is, the strongest evidence points to what you might have guessed. The most sold supplement worldwide is multivitamins, which are part of the even larger vitamins category. While there is no publicly available data that tracks every capsule, supplement, or powder sold worldwide, multivitamins make the strongest claim when all available usage data and market surveys are considered.
Publicly available market data supports that case. According to Grand View Research, the global dietary supplements market was estimated at $209.52 billion in 2025. Within that market, the vitamins segment accounted for 28.2% of global revenue, making vitamins the largest supplement ingredient segment. Grand View Research also estimated that the global multivitamin market reached $49.5 billion in 2025, with Asia Pacific as the largest market. That does not necessarily prove that every individual multivitamin pill outsells every other supplement ingredient on its own, but it does show that multivitamins are being sold at a scale few other supplement ingredients can match.
Usage data also points in the same direction. According to the National Institutes of Health’s Office of Dietary Supplements, multivitamin and multimineral supplements were the “most commonly consumed supplement.” That matters because the United States is one of the largest supplement markets in the world, and what is widely consumed there often reflects broader global demand.
Switching to ZYN: Why Doctors Say Smoke Free Nicotine Is Less Harmful Than Cigarettes
Older industry figures tell a similar story. A Reuters report citing supplement research scientist Paul Coates said that multivitamin supplements were “by far the most commonly consumed dietary supplements.” Reuters also cited figures from Nutrition Business Journal showing that in the United States, multivitamin and mineral supplements generated $5.4 billion of the $32.5 billion in total supplement sales in 2012, or nearly 17% of the market at the time. That is older U.S. data rather than a full global picture, but the pattern is the same. Multivitamins have been at the center of the dietary supplement market for a long time.
That is one reason the best-selling dietary supplement in the world is not a trendy ingredient like collagen, ashwagandha, or mushroom powders. Those may be among the hottest ingredients in the industry, but vitamins are still the strongest sellers. According to Grand View’s 2025 market outlook, vitamins remain the leading dietary supplement ingredient category worldwide. Its multivitamin market outlook also shows a category worth nearly $50 billion in annual revenue. That is the clearest sign of a leading segment in the supplement industry.
There is another reason multivitamins continue to lead. They are straightforward. One product, one daily routine, broad appeal. According to the NIH consumer fact sheet, “Among the most common types of multivitamin and mineral supplements are those that are taken once daily and contain all or most vitamins and minerals at levels close to those considered adequate through the Recommended Dietary Allowances.”
Of course, popularity and benefit are not the same, and that is where the story becomes more interesting. In June 2024, the NIH announced that for healthy adults, “daily multivitamin use was not associated with a lower risk of death.” That announcement was based on a study of nearly 390,000 healthy adults in the United States followed for more than 20 years. The National Cancer Institute, which led the study, said that “the analysis found no evidence of lower mortality from cancer, heart disease, or cerebrovascular disease” among regular multivitamin users.
This gap between popularity and evidence is what makes the multivitamin business so compelling. The most popular supplement in the world appears to succeed because of consumer demand for reassurance, convenience, and protection against possible nutritional gaps, not because there is proof that multivitamins are a good idea for every healthy adult. The NIH puts it plainly: “Many adults take multivitamins to help maintain or improve their health, but the benefits and harms of long-term multivitamin use are unknown.”
There are, of course, exceptions. The NIH notes that multivitamins may be relevant for specific groups. Its broader fact sheets explain that supplement needs can depend on age, diet, pregnancy, or deficiency status. That is an important distinction. A product can dominate the market and still not be a magic bullet.